PubMed · 6095112
Recombinant antibodies possessing novel effector functions.
Abstract
The introduction into lymphocytes of immunoglobulin-gene DNA that has been manipulated in vitro allows the production of novel antibodies. In this way, cell lines have been established that secrete hapten-specific antibodies in which the Fc portion has been replaced either with an active enzyme moiety or with polypeptide displaying c-myc antigenic determinants.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M S Neuberger, G T Williams, R O Fox. Recombinant antibodies possessing novel effector functions.. https://doi.org/10.1038/312604a0
Cite the original work for its findings. Save a collection to share your selection of sources.